This invention relates to a group of trisubstituted pyrido(2,3-d)pyrimidine derivatives, their pharmaceutically acceptable salts, N-oxides, solvates and enantiomers, possessing unexpectedly desirable pharmaceutical properties, in particular which are highly active immunosuppressive agents, and as such are useful in the treatment in transplant rejection and/or in the treatment of certain inflammatory diseases. These derivatives are also useful in preventing or treating cardiovascular disorders, disorders of the central nervous system, TNF-α related disorders and cell proliferative disorders.
本发明涉及一组三取代
吡啶[2,3-d]
嘧啶衍
生物,其药学上可接受的盐、N-氧化物、溶剂化物和对映体,具有出乎意料的良好药理特性,特别是高度活性的
免疫抑制剂,并因此在移植排斥和/或某些炎症性疾病的治疗中有用。这些衍
生物还有助于预防或治疗心血管疾病、中枢神经系统疾病、TNF-α相关疾病和细胞增殖性疾病。